Trademarkia Logo

United Kingdom

£
Trademark Search
SynOx Therapeutics

View On IPO.GOV.UK

Registered

on 3 Dec 2020

Last Applicant/ Owned by

Synox Therapeutics Limited

7/8 Wilton Terrace

Dublin 2, , D02 KC57

Serial Number

UK00003563709 filed on 3rd Dec 2020

Registration Number

UK00003563709 registered on
9th Apr 2021

Correspondent Information

Penningtons Manches Cooper LLP

9400 Garsington Road, Oxford Business Park

Oxford,

OX4 2HN

SynOx Therapeutics

humanised antibody-based drugs for the treatment, diagnosis, detection and/or prevention of cancer and/or other diseases; humanised antibody emactuzum Read More

Classification Information

Class [5]
Pharmaceutical Products

Humanised antibody-based drugs for the treatment, diagnosis, detection and/or prevention of cancer and/or other diseases; humanised antibody emactuzumab targeting the CSF1R (colony stimulating factor 1 receptor) in cancer; inhibitors of CSF1R and macrophage function for the treatment of cancer and/or other diseases; inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of TGCT (tenosynovial giant cell tumour)/PVNS (pigmented villonodular synovitis); compounds for the treatment, diagnosis, detection and/or prevention of cancer and/or other diseases; pharmaceutical products, preparations and substances for the treatment, diagnosis, detection and/or prevention of cancer and/or other diseases; biological preparations and substances for the treatment, diagnosis, detection and/or prevention of cancer and/or other diseases.

Mark Details

Serial Number

UK00003563709

Mark Type

Figurative

Kind of mark

Individual